Torskal SAS, a French oncology innovator developing non-ionizing plasmonic PTT for cancers, has partnered with Houston-based SaniMed as its fundraising and strategic business consultant for US and international markets. SaniMed’s expertise in life science investments and commercialization will drive Torskal’s expansion and clinical development. The alliance accelerates breakthrough treatment advancements.